Abstract The Infectious Diseases Society of America (IDSA) is committed to providing up-to-
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …

Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …

Stenotrophomonas maltophilia is an emerging multidrug-resistant global opportunistic
pathogen. The increasing incidence of nosocomial and community-acquired S. maltophilia …

Infection of the airways remains the primary cause of morbidity and mortality in persons with
cystic fibrosis (CF). This review describes salient features of the epidemiologies of microbial …

The gram-negative bacterium Stenotrophomonas maltophilia is increasingly recognized as
an important cause of nosocomial infection. Infection occurs principally, but not exclusively …

Stenotrophomonas maltophilia has emerged as an important opportunistic pathogen in the
debilitated host. S maltophilia is not an inherently virulent pathogen, but its ability to colonise …

Sulfonamides have a glorious history. In 1935, they were the first class of true antimicrobial
agents with life-saving potency. Today, 66 years later, increased bacterial resistance to …

As part of the SENTRY Antimicrobial Surveillance Program, a total of 1078 Acinetobacter
species and 842 Stenotrophomonas maltophilia isolates were collected between January …

Stenotrophomonas maltophilia has emerged as an important nosocomial pathogen capable
of causing respiratory, bloodstream, and urinary infections. The treatment of nosocomial …

In this review I will briefly survey the role of Pseudomonas aeruginosa, Acinetobacter
baumanii, Stenotrophomonas maltophilia, and Burkholderia cepacia as opportunistic …